Cytek Biosciences, Inc. CTKB Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s common stock?
- Cytek Biosciences, Inc. (CTKB) reported common stock of 1B in Q1 2026.
- How has Cytek Biosciences, Inc.'s common stock changed year-over-year?
- Cytek Biosciences, Inc.'s common stock increased by 781150.0% year-over-year, from 128K to 1B.
- What is the long-term trend for Cytek Biosciences, Inc.'s common stock?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s common stock has grown at a 746.6% compound annual growth rate (CAGR), from 23K to 1B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).